Loading...
Molecular and clinical characterization of PARP9 in gliomas: A potential immunotherapeutic target
BACKGROUND: Glioma is a primary malignancy of the central nervous system (CNS). As biomedicine advances, an efficient molecular target is urgently needed for the diagnosis and treatment of glioma. Meanwhile, several studies have demonstrated that glioma development is closely related to immunity. PA...
Na minha lista:
| Udgivet i: | CNS Neurosci Ther |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7366751/ https://ncbi.nlm.nih.gov/pubmed/32678519 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.13380 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|